DNA-Binding Properties of African Swine Fever Virus pA104R, a Histone-Like Protein Involved in Viral Replication and Transcription

Journal of Virology - Tập 91 Số 12 - 2017
Gonçalo Frouco1, Ferdinando B. Freitas1, João Coelho1, Alexandre Leitão1, Carlos Martins1, Fernando Ferreira1
1Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal

Tóm tắt

ABSTRACT African swine fever virus (ASFV) codes for a putative histone-like protein (pA104R) with extensive sequence homology to bacterial proteins that are implicated in genome replication and packaging. Functional characterization of purified recombinant pA104R revealed that it binds to single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) over a wide range of temperatures, pH values, and salt concentrations and in an ATP-independent manner, with an estimated binding site size of about 14 to 16 nucleotides. Using site-directed mutagenesis, the arginine located in pA104R's DNA-binding domain, at position 69, was found to be relevant for efficient DNA-binding activity. Together, pA104R and ASFV topoisomerase II (pP1192R) display DNA-supercoiling activity, although none of the proteins by themselves do, indicating that the two cooperate in this process. In ASFV-infected cells, A104R transcripts were detected from 2 h postinfection (hpi) onward, reaching a maximum concentration around 16 hpi. pA104R was detected from 12 hpi onward, localizing with viral DNA replication sites and being found exclusively in the Triton-insoluble fraction. Small interfering RNA (siRNA) knockdown experiments revealed that pA104R plays a critical role in viral DNA replication and gene expression, with transfected cells showing lower viral progeny numbers (up to a reduction of 82.0%), lower copy numbers of viral genomes (−78.3%), and reduced transcription of a late viral gene (−47.6%). Taken together, our results strongly suggest that pA104R participates in the modulation of viral DNA topology, probably being involved in viral DNA replication, transcription, and packaging, emphasizing that ASFV mutants lacking the A104R gene could be used as a strategy to develop a vaccine against ASFV. IMPORTANCE Recently reintroduced in Europe, African swine fever virus (ASFV) causes a fatal disease in domestic pigs, causing high economic losses in affected countries, as no vaccine or treatment is currently available. Remarkably, ASFV is the only known mammalian virus that putatively codes for a histone-like protein (pA104R) that shares extensive sequence homology with bacterial histone-like proteins. In this study, we characterized the DNA-binding properties of pA104R, analyzed the functional importance of two conserved residues, and showed that pA104R and ASFV topoisomerase II cooperate and display DNA-supercoiling activity. Moreover, pA104R is expressed during the late phase of infection and accumulates in viral DNA replication sites, and its downregulation revealed that pA104R is required for viral DNA replication and transcription. These results suggest that pA104R participates in the modulation of viral DNA topology and genome packaging, indicating that A104R deletion mutants may be a good strategy for vaccine development against ASFV.

Từ khóa


Tài liệu tham khảo

10.1016/j.vetmic.2012.11.030

10.1186/s40813-015-0013-y

10.1016/j.virusres.2012.10.030

10.1016/j.virusres.2012.10.026

King AMQ Adams MJ Carsten EB Lefkowitz EJ . 2012. Virus taxonomy: classification and nomenclature of viruses. Ninth Report of the International Committee on Taxonomy of Viruses, p 153–162. Elsevier Inc., Philadelphia, PA.

10.1016/j.virusres.2012.10.020

10.1093/nar/21.6.1496

10.1007/BF01718401

10.1074/jbc.M303970200

10.1073/pnas.0508032102

10.1371/journal.pone.0004367

10.1128/mBio.00182-11

10.1006/jmbi.1996.0086

10.1006/jmbi.1996.0068

10.1093/nar/gku804

10.1038/nrm831

10.1073/pnas.72.9.3428

10.1016/j.jsb.2006.05.006

Grove A . 2011. Functional evolution of bacterial histone-like HU proteins. Curr Issues Mol Biol 13:1–12.

10.1016/S0022-2836(02)00571-5

10.1016/j.bbagrm.2012.02.012

10.1093/nar/gkm506

10.1128/JVI.72.4.2917-2926.1998

10.1016/j.pt.2013.04.002

10.1016/j.virusres.2012.12.006

10.1074/jbc.M708691200

10.1128/JVI.00193-09

10.1128/JVI.02400-15

10.1128/JVI.78.19.10657-10673.2004

10.1074/jbc.272.13.8236

10.1371/journal.pone.0088809

10.1093/nar/29.13.2860

10.1016/j.virol.2016.03.023

10.1016/0042-6822(92)90558-7

10.1016/j.virol.2014.10.034

10.1016/j.antiviral.2016.08.021

10.1074/jbc.M605576200

10.1016/j.sbi.2003.12.003

10.1016/j.mib.2011.01.003

10.1128/JVI.72.3.2259-2264.1998

10.1128/JVI.01955-12

10.1128/JVI.79.5.2831-2838.2005

10.1021/bi0600796

10.1128/jvi.71.3.2331-2341.1997

10.1016/j.virusres.2012.09.016

10.1016/j.virusres.2015.07.006

10.3390/v7092858

10.1002/0471143030.cb2614s53

10.1007/BF01863914

10.1016/S0166-0934(02)00189-1